A novel role for human sulfiredoxin in the reversal of glutathionylation.

Cancer Res

Department of Molecular and Cellular Pharmacology, Medical University of South Carolina, Jonathan Lucas Street, Charleston, SC 29425, USA.

Published: July 2006

Modification of protein cysteine residues by disulfide formation with glutathione (glutathionylation) is a reversible posttranslational modification of critical importance in controlling cell signaling events following oxidative and/or nitrosative stress. Here, we show that human sulfiredoxin, a small redox protein conserved in eukaryotes, can act as a novel regulator of the redox-activated thiol switch in cells by catalyzing deglutathionylation of a number of distinct proteins in response to oxidative and/or nitrosative stress. Actin and protein tyrosine phosphatase 1B were identified in vitro as targets of sulfiredoxin 1 (Srx1)-dependent deglutathionylation and confirmed in vivo by two-dimensional gel electrophoresis analysis. In addition, we show that Srx1-dependent deglutathionylation is functionally relevant through restoration of phosphatase activity. Human sulfiredoxin contains one cysteine residue (Cys(99)) that is conserved in all family members. Mutation of the cysteine residue inhibits deglutathionylation but did not affect its capacity to bind intracellular proteins. Furthermore, sulfiredoxin is not an acceptor molecule for the GS(-) moiety during the reaction process. Using two-dimensional gel electrophoresis, we identified multiple protein targets in vivo that are deglutathionylated by sulfiredoxin following oxidative and/or nitrosative stress. This novel deglutathionylation function of sulfiredoxin suggests it has a central role in redox control with potential implications in cell signaling.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361143PMC
http://dx.doi.org/10.1158/0008-5472.CAN-06-0484DOI Listing

Publication Analysis

Top Keywords

human sulfiredoxin
12
oxidative and/or
12
and/or nitrosative
12
nitrosative stress
12
cell signaling
8
srx1-dependent deglutathionylation
8
two-dimensional gel
8
gel electrophoresis
8
cysteine residue
8
sulfiredoxin
7

Similar Publications

Article Synopsis
  • - The antioxidant protein sulfiredoxin-1 (SRX) is linked to tumor progression in colorectal cancer (CRC) and its degradation mechanism by Keap1, a protein that promotes its breakdown, was studied.
  • - Keap1 bound to SRX enhances its degradation via ubiquitination, and its absence leads to increased SRX levels, which accelerates CRC metastasis through the AP-1/MMP9 signaling pathway.
  • - Analysis suggests that reduced Keap1 and elevated SRX are associated with worse outcomes in CRC, highlighting the potential of targeting the Keap1-SRX axis for therapeutic strategies.
View Article and Find Full Text PDF

Background Aims: Liver fibrosis is characterized by the progressive scarring of liver tissue. Oxidative stress is a critical causal factor of hepatic stellate cell (HSC) activation and the subsequent liver fibrogenesis, but the mechanism is not fully understood. Cysteine sulfinic acid (Cys-SO2H), a modification of reactive cysteine residues, is a unique form of oxidative response that alters the structure and function of proteins.

View Article and Find Full Text PDF

Redox signaling in the pancreas in health and disease.

Physiol Rev

April 2025

Department of Physiology, Faculty of Pharmacy, University of Valencia, Valencia, Spain.

This review addresses oxidative stress and redox signaling in the pancreas under healthy physiological conditions as well as in acute pancreatitis, chronic pancreatitis, pancreatic cancer, and diabetes. Physiological redox homeodynamics is maintained mainly by NRF2/KEAP1, NF-κB, protein tyrosine phosphatases, peroxisome proliferator-activated receptor-γ coactivator 1α (PGC1α), and normal autophagy. Depletion of reduced glutathione (GSH) in the pancreas is a hallmark of acute pancreatitis and is initially accompanied by disulfide stress, which is characterized by protein cysteinylation without increased glutathione oxidation.

View Article and Find Full Text PDF
Article Synopsis
  • Doxorubicin (DOX) is limited in its clinical use due to cardiotoxicity caused by oxidative stress and inflammation, while the role of Sulfiredoxin 1 (Srxn1) in this process is not well understood.* -
  • In this study, researchers overexpressed Srxn1 in mice and found that it improved cardiac function and reduced injury by decreasing oxidative stress and inflammation caused by DOX treatment.* -
  • The study concluded that Srxn1 protects against DOX-induced cardiac damage by modulating the Sirt1/NLRP3 signaling pathway, suggesting it could be a promising therapeutic target for preventing myocardial injury from DOX.*
View Article and Find Full Text PDF

Advanced hepatocellular carcinoma (HCC) patients have poor prognosis. As an endogenous antioxidant enzyme involved in a variety of bioprocesses, sulfiredoxin-1 (SRXN1) plays an irreplaceable role in promoting the development of tumors. However, the role and working mechanism of SRXN1 in HCC remain unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!